ARAMCHOL
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Nov 2022)
What this means for you
This application is over — abandoned 07 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88071603
- Mark type
- Stylized text
- Filed
- 09 Aug 2018
- Published for opposition
- 06 Aug 2019
- Abandoned
- 07 Nov 2022
- Attorney of record
- Ann K. Ford
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) being medical therapeutics for treatment of liver diseases and fibrosis; pharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) for the treatment of liver diseases and cholesterol gallstones
Owner
- Galmed Pharmaceuticals Ltd., Tel Aviv, IL
- Galmed Pharmaceuticals Ltd., Tel Aviv, IL
Prosecution history
- 07 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Oct 2022 — PETITION TO DIRECTOR DENIED
- 12 Oct 2022 — ASSIGNED TO PETITION STAFF
- 28 Sept 2022 — 44(e) PETITION - RECEIVED
- 28 Sept 2022 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 06 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Apr 2022 — SOU EXTENSION 5 GRANTED
- 31 Mar 2022 — SOU EXTENSION 5 FILED
- 05 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2021 — SOU EXTENSION 4 GRANTED
- 29 Sept 2021 — SOU EXTENSION 4 FILED
- 29 Sept 2021 — SOU TEAS EXTENSION RECEIVED